[{"Assets_0_Q3_USD":319579000.0,"CommonStockSharesOutstanding_0_Q3_shares":14269000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":23983000.0,"NetIncomeLoss_1_Q3_USD":9200000.0,"NetIncomeLoss_3_Q3_USD":23142000.0,"StockholdersEquity_0_Q3_USD":281682000.0,"EarningsPerShareBasic_1_Q3_USD":0.65,"EarningsPerShareBasic_3_Q3_USD":1.65,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":14070000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":14065000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20191028"}]